GSK-1292263 (hydrochloride) is an orally active GPR119 agonist ( pEC 50 of approximately 6.9 and 6.7 nM for human and rat GPR119 , respectively). GSK-1292263 is used in the research of type 2 diabetes and dyslipidemia.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > GPR119
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.